CMPX logo

Compass Therapeutics (CMPX) EBIT

Annual EBIT

-$50.36 M
-$8.71 M-20.91%

December 31, 2023


Summary


Performance

CMPX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMPXprofitabilitymetrics:

Quarterly EBIT

-$12.24 M
+$2.81 M+18.65%

September 1, 2024


Summary


Performance

CMPX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMPXprofitabilitymetrics:

TTM EBIT

-$55.45 M
-$313.00 K-0.57%

September 1, 2024


Summary


Performance

CMPX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMPXprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CMPX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-20.9%+4.2%-3.8%
3 y3 years-76.3%+4.2%-3.8%
5 y5 years-34.6%+4.2%-3.8%

CMPX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-20.9%+38.4%-70.4%+20.5%-58.3%+32.2%
5 y5-year-76.3%+38.4%-131.0%+78.0%-141.1%+32.2%
alltimeall time-76.3%+38.4%-131.0%+78.0%-554.7%+32.2%

Compass Therapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$12.24 M(-18.7%)
-$55.45 M(+0.6%)
Jun 2024
-
-$15.04 M(+17.8%)
-$55.13 M(+3.2%)
Mar 2024
-
-$12.77 M(-17.0%)
-$53.43 M(+6.1%)
Dec 2023
-$50.36 M(+20.9%)
-$15.39 M(+29.1%)
-$50.37 M(+5.2%)
Sep 2023
-
-$11.93 M(-10.6%)
-$47.86 M(-1.4%)
Jun 2023
-
-$13.34 M(+37.3%)
-$48.53 M(+9.8%)
Mar 2023
-
-$9.71 M(-24.7%)
-$44.18 M(+6.1%)
Dec 2022
-$41.66 M(-49.1%)
-$12.89 M(+2.3%)
-$41.66 M(-0.2%)
Sep 2022
-
-$12.60 M(+40.2%)
-$41.72 M(+19.1%)
Jun 2022
-
-$8.99 M(+25.1%)
-$35.02 M(-57.1%)
Mar 2022
-
-$7.18 M(-44.6%)
-$81.71 M(-0.1%)
Dec 2021
-$81.81 M
-
-
DateAnnualQuarterlyTTM
Dec 2021
-
-$12.96 M(+119.7%)
-$81.81 M(+6.2%)
Sep 2021
-
-$5.90 M(-89.4%)
-$77.07 M(-3.8%)
Jun 2021
-
-$55.68 M(+664.8%)
-$80.11 M(+169.5%)
Mar 2021
-
-$7.28 M(-11.4%)
-$29.73 M(+4.1%)
Dec 2020
-$28.56 M(-14.6%)
-$8.21 M(-8.1%)
-$28.56 M(+7.1%)
Sep 2020
-
-$8.94 M(+68.7%)
-$26.66 M(+2.8%)
Jun 2020
-
-$5.30 M(-13.3%)
-$25.94 M(-10.9%)
Mar 2020
-
-$6.11 M(-3.3%)
-$29.11 M(+26.6%)
Dec 2019
-$33.42 M(-10.7%)
-$6.32 M(-23.1%)
-$23.00 M(+37.9%)
Sep 2019
-
-$8.21 M(-3.0%)
-$16.68 M(+97.0%)
Jun 2019
-
-$8.47 M
-$8.47 M
Dec 2018
-$37.42 M
-
-

FAQ

  • What is Compass Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Compass Therapeutics?
  • What is Compass Therapeutics annual EBIT year-on-year change?
  • What is Compass Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Compass Therapeutics?
  • What is Compass Therapeutics quarterly EBIT year-on-year change?
  • What is Compass Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Compass Therapeutics?
  • What is Compass Therapeutics TTM EBIT year-on-year change?

What is Compass Therapeutics annual earnings before interest & taxes?

The current annual EBIT of CMPX is -$50.36 M

What is the all time high annual EBIT for Compass Therapeutics?

Compass Therapeutics all-time high annual earnings before interest & taxes is -$28.56 M

What is Compass Therapeutics annual EBIT year-on-year change?

Over the past year, CMPX annual earnings before interest & taxes has changed by -$8.71 M (-20.91%)

What is Compass Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of CMPX is -$12.24 M

What is the all time high quarterly EBIT for Compass Therapeutics?

Compass Therapeutics all-time high quarterly earnings before interest & taxes is -$5.30 M

What is Compass Therapeutics quarterly EBIT year-on-year change?

Over the past year, CMPX quarterly earnings before interest & taxes has changed by +$531.00 K (+4.16%)

What is Compass Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of CMPX is -$55.45 M

What is the all time high TTM EBIT for Compass Therapeutics?

Compass Therapeutics all-time high TTM earnings before interest & taxes is -$8.47 M

What is Compass Therapeutics TTM EBIT year-on-year change?

Over the past year, CMPX TTM earnings before interest & taxes has changed by -$2.02 M (-3.78%)